BLB&B Advisors’s Outset Medical OM Stock Holding History

BLB&B Advisors’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,066	Closed	-$17.7K	–	283
2024 Q4	$17.7K	Hold	1,066	–	–	﹤0.01%	269
2024 Q3	$10.8K	Hold	1,066	–	–	﹤0.01%	281
2024 Q2	$61.5K	Hold	1,066	–	–	﹤0.01%	273
2024 Q1	$35.5K	Hold	1,066	–	–	﹤0.01%	277
2023 Q4	$86.5K	Hold	1,066	–	–	0.01%	255
2023 Q3	$174K	Buy	+1,066	New	+$252K	0.01%	236

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

BLB&B Advisors's OM Position: Q1 2025 in Review

BLB&B Advisors sold out of Outset Medical (OM) in Q1 2025, closing a stake of 1,066 shares — an estimated $17.7K sold.

BLB&B Advisors first reported a position in OM in Q3 2023 and held it in 6 quarters. The position peaked at $174K in Q3 2023. 61 funds tracked by Wall St. Rank hold OM as of Q1 2025.

BLB&B Advisors reported no remaining Outset Medical position as of Q1 2025 after selling out during the quarter.
BLB&B Advisors sold 1,066 Outset Medical shares in Q1 2025, an estimated $17.7K.
BLB&B Advisors first reported a position in Outset Medical in Q3 2023 and held it in 6 quarters.
BLB&B Advisors's Outset Medical position peaked at $174K in Q3 2023.
61 funds tracked by Wall St. Rank held Outset Medical as of Q1 2025.

Based on BLB&B Advisors's 13F filing for Q1 2025, filed 28 Apr 2025.